Sort
48,018 grants matching “immunotherapy”
Cellular Immunity/JC Virus/AIDS/Leukoencephalopathy
$362,299Igor J Koralnik · Beth Israel Deaconess Medical Center · R01 · FY2007 · NS
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease
$362,294Thomas M Wisniewski · New York University School Of Medicine · R01 · FY2012 · NS
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease
$362,294Thomas M Wisniewski · New York University School Of Medicine · R01 · FY2011 · NS
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers
$362,294Catherine C Hedrick · La Jolla Institute For Immunology · U01 · FY2019 · CA
Plasma Membrane Proteins in Myeloid-Derived Suppressor Cells
$362,254Catherine C. Fenselau · Univ Of Maryland, College Park · R01 · FY2011 · GM
Crosstalk between butyrophilins and gamma delta T cells in human cancer
$362,250Jose R Conejo-Garcia · Duke University · R01 · FY2025 · CA
Crosstalk between butyrophilins and gamma delta T cells in human cancer
$362,250Jose R Conejo-Garcia · Duke University · R01 · FY2024 · CA
Targetable Immune Evasion Pathways in Hodgkin Lymphoma
$362,197Margaret A Shipp · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Immunosuppression and Metabolic Rewiring in Tumor-infiltrating Neutrophils
$362,196Xin Lu · University Of Notre Dame · R01 · FY2025 · CA
Project 1: Genomic Predictors of Clinical Outcomes and Response to Targeted Therapy in Advanced Prostate Cancer
$362,142David B. Solit · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Signature-guided therapy for mismatch repair defective cancers
$362,131Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Non-deletional CD8 T cell self-tolerance
$362,126Stephen C Jameson · University Of Minnesota · P01 · FY2019 · AI
Research Training in Academic Medical Oncology
$362,121Michael Davies · University Of Tx Md Anderson Can Ctr · T32 · FY2020 · CA
Bispecific T cell engagers for the treatment of pancreatic ductal adenocarcinoma
$362,118Nathan G. Dolloff · Leukogene Therapeutics, Inc. · R41 · FY2021 · CA
DC exosome therapy to resolve inflammatory bone loss and oral infection
$362,093Christopher W Cutler · Augusta University · R01 · FY2022 · DE
Immune-Mediated Mechanisms Underlying CNS Abeta Clearance
$362,080Mayo Clinic Jacksonville · R01 · FY2005 · AG
Glioma immunotherapy targeting IDH mutation-derived epitope and immunosuppression
$362,043Hideho Okada · University Of California, San Francisco · R01 · FY2022 · CA
Self-assembled multifunctional aptamer-complex biomaterial for precision medicine
$362,043Youli Zu · Methodist Hospital Research Institute · R01 · FY2022 · CA
Replication stress response defects predict and enhance immune checkpoint therapy response in triple negative breast cancer
$362,016Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Replication stress response defects predict and enhance immune checkpoint therapy response in triple negative breast cancer
$362,016Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Structural Biology Core
$362,000Ian A Wilson · Scripps Research Institute, The · P01 · FY2024 · AI
Structural Biology Core
$362,000Ian A Wilson · Scripps Research Institute, The · P01 · FY2025 · AI
Structural Biology Core
$362,000Ian A Wilson · Scripps Research Institute, The · P01 · FY2023 · AI
Cellular Immunity/JC Virus/AIDS/Leukoencephalopathy
$361,986Igor J Koralnik · Beth Israel Deaconess Medical Center · R01 · FY2008 · NS
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery
$361,974Marxa L. Figueiredo · Purdue University · R01 · FY2016 · CA